Nanotechnology-Based Drug Delivery to Improve the Therapeutic Benefits of NRF2 Modulators in Cancer Therapy

The disadvantages of conventional anticancer drugs, such as their low bioavailability, poor targeting efficacy, and serious side effects, have led to the discovery of new therapeutic agents and potential drug delivery systems. In particular, the introduction of nano-sized drug delivery systems (NDDS...

Descripción completa

Detalles Bibliográficos
Autores principales: Sezgin-Bayindir, Zerrin, Losada-Barreiro, Sonia, Bravo-Díaz, Carlos, Sova, Matej, Kristl, Julijana, Saso, Luciano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145905/
https://www.ncbi.nlm.nih.gov/pubmed/33925605
http://dx.doi.org/10.3390/antiox10050685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145905/
https://www.ncbi.nlm.nih.gov/pubmed/33925605
http://dx.doi.org/10.3390/antiox10050685

Ejemplares similares